Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease

J. D. Cooper, E. P. Trulock, A. N. Triantafillou, G. A. Patterson, M. S. Pohl, P. A. Deloney, R. S. Sundaresan, C. L. Roper

Research output: Contribution to journalArticle

820 Scopus citations

Abstract

We undertook surgical bilateral lung volume reduction in 20 patients with severe chronic obstructive pulmonary disease to relieve thoracic distention and improve respiratory mechanics. The operation, done through median sternotomy, involves excision of 20% to 30% of the volume of each lung. The most affected portions are excised with the use of a linear stapling device fitted with strips of bovine pericardium attached to both the anvil and the cartridge to buttress the staple lines and eliminate air leakage through the staple holes. Preoperative and postoperative assessment of results has included grading of dyspnea and quality of life, exercise performance, and objective measurements of lung function by spirometry and plethysmography. There has been no early or late mortality and no requirement for immediate postoperative ventilatory assistance. Follow-up ranges from 1 to 15 months (mean 6.4 months). The mean forced expiratory volume in 1 second has improved by 82% and the reduction in total lung capacity, residual volume, and trapped gas has been highly significant. These changes have been associated with marked relief of dyspnea and improvement in exercise tolerance and quality of life. Although the follow-up period is short, these preliminary results suggest that bilateral surgical volume reduction may be of significant value for selected patients with severe chronic obstructive pulmonary disease. (J Thorac Cardiovasc Surg 1995;109:106-9).

Original languageEnglish
Pages (from-to)106-119
Number of pages14
JournalThe Journal of Thoracic and Cardiovascular Surgery
Volume109
Issue number1
DOIs
StatePublished - Jan 1995
Externally publishedYes

Fingerprint Dive into the research topics of 'Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

  • Cite this